Free Trial

9,776 Shares in McKesson Corporation $MCK Purchased by Seaview Investment Managers LLC

McKesson logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Seaview Investment Managers opened a new position in McKesson, buying 9,776 shares worth about $8.0 million. The stake now represents roughly 3% of its portfolio.
  • Institutional interest in McKesson remains high, with 85.07% of shares held by institutions and hedge funds. Several firms recently boosted their positions, including Swedbank AB, SurgoCap Partners, and Robeco.
  • Analysts are still broadly positive on the stock, with 14 Buy ratings and a consensus Moderate Buy target of about $968.87. McKesson also beat quarterly EPS estimates, though revenue came in below expectations.
  • Five stocks to consider instead of McKesson.

Seaview Investment Managers LLC acquired a new position in McKesson Corporation (NYSE:MCK - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 9,776 shares of the company's stock, valued at approximately $8,019,000. McKesson accounts for approximately 3.0% of Seaview Investment Managers LLC's investment portfolio, making the stock its 19th biggest position.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MCK. Swedbank AB increased its position in McKesson by 42.2% in the fourth quarter. Swedbank AB now owns 886,283 shares of the company's stock worth $727,009,000 after purchasing an additional 263,189 shares during the period. SurgoCap Partners LP increased its position in McKesson by 68.7% in the third quarter. SurgoCap Partners LP now owns 452,261 shares of the company's stock worth $349,390,000 after purchasing an additional 184,106 shares during the period. Robeco Institutional Asset Management B.V. increased its position in McKesson by 73.7% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 432,578 shares of the company's stock worth $354,839,000 after purchasing an additional 183,590 shares during the period. Danica Pension Livsforsikringsaktieselskab acquired a new stake in McKesson in the third quarter worth about $135,352,000. Finally, Danske Bank A S acquired a new stake in McKesson in the third quarter worth about $127,487,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on MCK shares. Raymond James Financial set a $970.00 target price on McKesson in a research report on Thursday, March 5th. Wells Fargo & Company decreased their target price on McKesson from $925.00 to $812.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 12th. Leerink Partners restated an "outperform" rating and set a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Wall Street Zen upgraded McKesson from a "hold" rating to a "buy" rating in a research report on Saturday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $875.00 target price on shares of McKesson in a research report on Friday, May 8th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of "Moderate Buy" and an average target price of $968.87.

Check Out Our Latest Report on MCK

McKesson Stock Performance

Shares of MCK opened at $765.30 on Tuesday. The stock has a 50 day simple moving average of $834.66 and a 200 day simple moving average of $855.23. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The firm has a market capitalization of $91.99 billion, a PE ratio of 19.89, a P/E/G ratio of 1.14 and a beta of 0.35.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion during the quarter, compared to analyst estimates of $101.35 billion. During the same period in the previous year, the firm earned $10.12 EPS. McKesson's quarterly revenue was up 6.0% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities research analysts predict that McKesson Corporation will post 44.29 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be given a $0.82 dividend. The ex-dividend date is Monday, June 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson's payout ratio is currently 8.53%.

Insider Activity

In other McKesson news, EVP Michele Lau sold 2,725 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.08% of the company's stock.

About McKesson

(Free Report)

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Further Reading

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in McKesson Right Now?

Before you consider McKesson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.

While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines